Klotho Neurosciences, Stock Today
| KLTO Stock | 0.28 0.01 3.45% |
PerformanceVery Weak
| Odds Of DistressBelow Average
|
Klotho Neurosciences, is selling at 0.28 as of the 20th of March 2025; that is 3.45% down since the beginning of the trading day. The stock's open price was 0.29. Klotho Neurosciences, has about a 34 percent probability of financial distress in the next few years of operation and has generated negative returns over the last 90 days. Klotho Neurosciences, symbol was changed from RWOD,WENA on 17th of September 2024. The performance scores are derived for the period starting the 20th of December 2024 and ending today, the 20th of March 2025. Click here to learn more.
Moving against Klotho Stock
Klotho Stock Highlights
| Older Symbol | RWOD |
| CEO, Founder | Joseph PharmD |
| Business Concentration | Pharmaceutical Products, Biotechnology, Healthcare, Health Care, Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care (View all Sectors) |
Klotho Neurosciences, (KLTO) is traded on NASDAQ Exchange in USA. It is located in 13576 Walnut Street, Omaha, NE, United States, 68144 and employs 5 people. Klotho Neurosciences, was previously known as RWOD Old and was traded on NASDAQ Exchange under the symbol RWOD. Klotho Neurosciences, is listed under Pharmaceutical Products category by Fama And French industry classification. The company currently falls under 'Micro-Cap' category with a current market capitalization of 17.65 M. Klotho Neurosciences, conducts business under Biotechnology sector and is part of Health Care industry. The entity has 21.26 M outstanding shares of which 34.58 K shares are now shorted by private and institutional investors with about 0.08 trading days to cover.
Klotho Neurosciences, generates negative cash flow from operations
Check Klotho Neurosciences, Probability Of Bankruptcy
Ownership AllocationKlotho Neurosciences, maintains a total of 21.26 Million outstanding shares. Klotho Neurosciences, secures majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 80.25 % of Klotho Neurosciences, outstanding shares that are owned by insiders conveys that they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Klotho Ownership Details
Klotho Neurosciences, Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. Klotho Neurosciences, market risk premium is the additional return an investor will receive from holding Klotho Neurosciences, long position in a well-diversified portfolio.
| Risk Adjusted Performance | (0.05) | |||
| Jensen Alpha | (0.48) | |||
| Total Risk Alpha | 0.1752 | |||
| Treynor Ratio | (5.43) |
Klotho Stock Against Markets
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Klotho Neurosciences,. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. To learn how to invest in Klotho Stock, please use our How to Invest in Klotho Neurosciences, guide.You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Is Pharmaceutical Products space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Klotho Neurosciences,. If investors know Klotho will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Klotho Neurosciences, listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Klotho Neurosciences, is measured differently than its book value, which is the value of Klotho that is recorded on the company's balance sheet. Investors also form their own opinion of Klotho Neurosciences,'s value that differs from its market value or its book value, called intrinsic value, which is Klotho Neurosciences,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Klotho Neurosciences,'s market value can be influenced by many factors that don't directly affect Klotho Neurosciences,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Klotho Neurosciences,'s value and its price as these two are different measures arrived at by different means. Investors typically determine if Klotho Neurosciences, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Klotho Neurosciences,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.